Back to
HRT FINANCIAL LP
AIM2 quarters
Position history for
HRT FINANCIAL LP's holdings in AIM IMMUNOTECH INC COM NEW
No. HRT Financial exited its AIM (Aim Immunotech) position in Q2 2026. Its Q1 2026 13F listed 26,032 shares worth $15,000. HRT Financial first reported AIM in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$15,000
Total Shares Change
-26,032
Quarter-by-Quarter History
Other major holders of AIM: JANE STREET GROUP, LLC, Corient Private Wealth LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC